Wordt geladen...
Rituximab Resistance
Rituximab has become a ubiquitous component of treatment regimens for follicular non-Hodgkin lymphoma. Despite widespread clinical use, the mechanisms by which tumor cells resist rituximab-mediated destruction remain unclear. Rituximab relies in part on immune effector mechanisms for its antitumor e...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3113665/ https://ncbi.nlm.nih.gov/pubmed/21658619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beha.2011.02.009 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|